세포 투과 시장 : 제품 유형, 용도, 최종 용도별 - 세계 예측(2024-2032년)

Global Cell Permeabilization Market will register a 4.3% CAGR from 2024 to 2032, owing to advancements in cellular analysis technologies and the rising adoption of flow cytometry and other analytical techniques. As new technologies, such as high-speed imaging and spectral sorting, enhance the capabilities of cellular analysis, they require advanced cell permeabilization methods to ensure accurate and detailed results. The demand for effective permeabilization techniques grows alongside these innovations, supporting the development of more sophisticated and efficient methods to prepare cells for cutting-edge analytical procedures.

For instance, in May 2023, BD (Becton, Dickinson and Company) launched the first-ever spectral cell sorter with high-speed imaging, integrating two groundbreaking technologies to reveal detailed cellular information previously hidden in traditional flow cytometry. The introduction of these innovative technologies will likely drive growth in the cell permeabilization industry by enhancing the need for precise and efficient cell preparation techniques, ultimately advancing research capabilities and expanding applications in various scientific fields.

The cell permeabilization market is divided based on product type, application, end-use, and region.

The detergent segment will witness remarkable expansion through 2032 due to its effectiveness and versatility. Detergents are widely used for permeabilizing cell membranes, allowing for the efficient extraction of intracellular components, and facilitating various biochemical and molecular biology applications. Their ability to selectively solubilize membrane proteins while preserving cellular integrity makes them indispensable in research and diagnostics. As demand for advanced cellular analysis techniques grows, the use of detergents in cell permeabilization continues to expand, solidifying their market dominance.

The cellular imaging segment will garner considerable gains by 2032, attributed to its crucial role in visualizing and analyzing cellular structures. Permeabilization techniques are essential for preparing cells for imaging, allowing researchers to study intracellular processes and molecular interactions with high precision. Advances in imaging technologies, including fluorescence and confocal microscopy, require effective permeabilization to ensure clear and accurate results. The growing demand for detailed cellular analysis and imaging solutions drives a significant share of this segment in the market.

Europe cell permeabilization industry share will reach a noteworthy CAGR during 2024 and 2032, propelled by its advanced research infrastructure and high investment in biomedical research and development. The region's robust academic and industrial sectors drive innovation and demand for sophisticated cell permeabilization techniques. Additionally, Europe's stringent regulations and high standards for research quality contribute to the adoption of advanced technologies. The combination of strong research capabilities and regulatory support positions Europe as a key contributor to the growth and development of the cell permeabilization market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of chronic diseases
    • 3.2.1.2 Advancements in cell-based therapies
    • 3.2.1.3 Increasing biomedical research activities
    • 3.2.1.4 Growing focus on personalized medicine
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High costs of technology development and implementation
    • 3.2.2.2 Limited standardization of techniques
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Detergent
• 5.3 Organic solvent
• 5.4 Pore-forming agents
• 5.5 Enzymatic permeabilization
• 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Drug delivery
• 6.3 Gene transfection
• 6.4 Cellular imaging
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Contract research organizations
• 7.3 Pharmaceutical and biotechnology companies
• 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Agilent Technologies, Inc.
• 9.2 Boster Biological Technology
• 9.3 Cell Signaling Technology, Inc.
• 9.4 Cyanagen
• 9.5 Danaher Corporation
• 9.6 F. Hoffmann-La Roche Ltd.
• 9.7 Illumina, Inc.
• 9.8 International Stem Cell Corporation
• 9.9 IQ Products
• 9.10 PerkinElmer, Inc.
• 9.11 Promega Corporation
• 9.12 Qiagen N.V.
• 9.13 Sartorius AG
• 9.14 Standard Biotools Inc.
• 9.15 Thermo Fisher Scientific, Inc.